Stability of adenoviral vectors following catheter delivery

Molecular Therapy

Volumn 3, Issue 1, 2001, Pages 122-125

  Tsui, Lisa V ^a   Zayek, Nathalie ^a   Frey, David ^a   Mello, Christopher ^a   Banik, Gautam ^a   Falotico, Robert ^b   McArthur, James G ^a  

^a CELL GENESYS INC   (United States)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

Adenovirus; Catheter; Intravascular

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL; CATHETER; CONTROLLED STUDY; CORONARY ARTERY; DISEASE MODEL; DRUG DELIVERY SYSTEM; GENE THERAPY; HUMAN; HUMAN CELL; INCUBATION TIME; INFUSION; INTRAARTERIAL DRUG ADMINISTRATION; METHODOLOGY; MOLECULAR STABILITY; NONHUMAN; POROSITY; TEMPERATURE; VASCULAR DISEASE; VIRUS INFECTIVITY; VIRUS PARTICLE;

ADENOVIRIDAE;

EID: 0034991460     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0237     Document Type: Article

References (9)

1. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
2. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty
3. Adventitial gene transfer to arterial wall
4. Biocompatibility of cardiovascular gene delivery catheters with adenovirus vectors: An important determinant of the efficiency of cardiovascular gene transfer
5. Analysis of adenoviral transport mechanisms in the vessel wall and optimization of gene transfer using local delivery catheters
6. The Dispatch catheter as a delivery tool for arterial gene transfer
7. Percutaneous adenoviral gene transfer into porcine coronary arteries: Is catheter-based gene delivery adapted to coronary circulation?
8. Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector
9. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury